CA2388614A1 - Preparations de principes actifs pharmaceutiques - Google Patents

Preparations de principes actifs pharmaceutiques Download PDF

Info

Publication number
CA2388614A1
CA2388614A1 CA002388614A CA2388614A CA2388614A1 CA 2388614 A1 CA2388614 A1 CA 2388614A1 CA 002388614 A CA002388614 A CA 002388614A CA 2388614 A CA2388614 A CA 2388614A CA 2388614 A1 CA2388614 A1 CA 2388614A1
Authority
CA
Canada
Prior art keywords
active ingredient
component
dosage form
weight
solid dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002388614A
Other languages
English (en)
Inventor
Robert Heger
Jorg Breitenbach
Gunther Berndl
Rudolf Binder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2388614A1 publication Critical patent/CA2388614A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des formes galéniques pharmaceutiques solides contenant un principe actif sous forme de mélange physique d'au moins deux préparations différentes en termes d'état physique du principe actif.
CA002388614A 1999-10-26 2000-10-17 Preparations de principes actifs pharmaceutiques Abandoned CA2388614A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19951617.0 1999-10-26
DE19951617A DE19951617A1 (de) 1999-10-26 1999-10-26 Zubereitungen pharmazeutische Wirkstoffe
PCT/EP2000/010205 WO2001030372A2 (fr) 1999-10-26 2000-10-17 Preparations de principes actifs pharmaceutiques

Publications (1)

Publication Number Publication Date
CA2388614A1 true CA2388614A1 (fr) 2001-05-03

Family

ID=7926968

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002388614A Abandoned CA2388614A1 (fr) 1999-10-26 2000-10-17 Preparations de principes actifs pharmaceutiques

Country Status (7)

Country Link
EP (1) EP1223960A2 (fr)
JP (1) JP2004500343A (fr)
CN (1) CN1384753A (fr)
CA (1) CA2388614A1 (fr)
DE (1) DE19951617A1 (fr)
PL (1) PL354991A1 (fr)
WO (1) WO2001030372A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0816053B2 (ja) * 1986-12-04 1996-02-21 大正製薬株式会社 貼付剤の製造方法
JPH0436237A (ja) * 1990-06-01 1992-02-06 Taiho Yakuhin Kogyo Kk 抗腫瘍性複合製剤
AU671964B2 (en) * 1991-12-05 1996-09-19 Alfatec-Pharma Gmbh Peroral administration form for peptidic medicaments, in particular insulin
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
JP4189044B2 (ja) * 1997-07-01 2008-12-03 大正製薬株式会社 マルチプルユニットタイプ徐放性錠剤

Also Published As

Publication number Publication date
PL354991A1 (en) 2004-03-22
WO2001030372A2 (fr) 2001-05-03
WO2001030372A3 (fr) 2001-11-01
DE19951617A1 (de) 2001-05-03
JP2004500343A (ja) 2004-01-08
CN1384753A (zh) 2002-12-11
EP1223960A2 (fr) 2002-07-24

Similar Documents

Publication Publication Date Title
US6599528B1 (en) Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances
US8349366B2 (en) Immediate release pharmaceutical granule compositions and a continuous process for making them
US6511681B2 (en) Aqueous solubility pharmaceutical formulations
JP3722293B2 (ja) 新規な薬学的固体分散物
US7273624B2 (en) Stable dosage forms containing ubiquinones
KR100694667B1 (ko) 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
CN101594851B (zh) 用于口服给药的酪氨酸激酶抑制剂的药物剂型
PL202757B1 (pl) Środek farmaceutyczny, sposób wytwarzania środka farmaceutycznego, kompleks nierozpuszczalny w wodzie i sposób wytwarzania nierozpuszczalnego w wodzie kompleksu
KR20230107902A (ko) Cgrp-활성 화합물에 대한 정제 제제
CA2253769C (fr) Composes pharmaceutiques a base de fenofibrate
AU2016372683A1 (en) Complexes of celecoxib and its salts and derivatives process for the preparation thereof and pharmaceutical compositions containing them
JP4926319B2 (ja) 固体医薬剤形のための粉末形態の可溶化賦形剤
CA2301042A1 (fr) Systeme d'apport de medicaments a regulation micro-osmotique
JP2013505222A (ja) 親水性ポリマーと組み合わせたポリエーテルに基づく両親媒性コポリマーを含有する速溶性固体医薬製剤
JP2004500343A (ja) 医薬製剤
KR100956583B1 (ko) 유비데카레논의 고체분산체와 그 제조방법 및 이를포함하는 약제학적 조성물
EP2540281A1 (fr) Systèmes à auto-microémulsion solide
JP2002515415A (ja) シクロスポリン製剤
CN113081970A (zh) 一种环孢素固体分散体及其片剂制备方法
KR20210150501A (ko) Hcv를 치료하기 위한 고체 약제학적 조성물
JP2813792B2 (ja) マレイン酸イルソグラジン経口投与用製剤およびその製造法
Dahiya et al. INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES
JPWO1997033571A1 (ja) エカドトリルの速放微分散性製剤
MXPA01009542A (en) Improved aqueous solubility pharmaceutical formulations

Legal Events

Date Code Title Description
FZDE Dead